KinDex Pharmaceuticals Receives $500,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
    KinDex Pharmaceuticals
  • Mailing Address
    800 Fifth Avenue Seattle, WA 98104 USA
  • Company Description
    KinDex was established in the fall of 2009 to focus on the discovery and development of molecules that modulate key regulatory networks associated with chronic disease.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing – amended. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy